VACCINES RECOMBINANT VECTORS

Brand Owner (click to sort) Address Description
ALVAC CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 vaccines and recombinant vectors of canary pox used to prepare vaccines and biological immunogens for use in animals and humans;
PANVAC Therion Biologics Corporation 76 Rogers Street Cambridge MA 02142 Vaccines and recombinant vectors of pox used to prepare vaccines and biological immunogens for use in the treatment of pancreatic cancer;PANCREATIC VACCINE;
PANVAX Therion Biologics Corporation 76 Rogers Street Cambridge MA 02142 Vaccines and recombinant vectors of pox used to prepare vaccines and biological immunogens for use in the treatment of pancreatic cancer;
PROSTVAC Therion Biologics Corporation 76 Rogers Street Cambridge MA 02142 Vaccines and recombinant vectors of pox used to prepare vaccines and biological immunogens for use in humans;
TRICOM Therion Biologics Corporation 76 Rogers Street Cambridge MA 02142 Vaccines and recombinant vectors of pox and component immune-stimulatory agents used in said vaccines to produce biological immunogens for use in humans;
TROVAC Virogenetics Corporation 465 Jordan Road Rensselaer Technology Park Troy NY 12180 vaccines and recombinant vectors of fowl pox used to prepare vaccines and biological immunogens for use in fowl;
TROVAC MERIAL LIMITED SANDRINGHAM HOUSE, SANDRINGHAM AVENUE HARLOW BUSINESS PARK HARLOW ESSEX CM19 5QA United Kingdom vaccines and recombinant vectors of fowl pox used to prepare vaccines and biological immunogens for use in fowl;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the site of a naturally occurring deletion in the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy, and the use of such recombinant MVA viruses encoding antigens as vaccines.